Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
23,165,208
-
Total 13F shares
-
11,217,203
-
Share change
-
+814,706
-
Total reported value
-
$68,541,901
-
Price per share
-
$6.11
-
Number of holders
-
38
-
Value change
-
+$4,868,272
-
Number of buys
-
32
-
Number of sells
-
10
Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) as of Q2 2025
As of 30 Jun 2025 ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,217,203 shares of stock of the company.
Largest 10 holders included BIOS Capital Management, LP, Voss Capital, LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BARCLAYS PLC, STATE STREET CORP, NORTHWESTERN UNIVERSITY, and Gleason Group, Inc..
This table shows 38 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.